Article
<i>PCSK9</i>genetic variants and risk of vascular and non-vascular diseases in Chinese and UK populations
2023-08-16
Abstract excerpt
<h4>Background</h4> Lowering low-density lipoprotein cholesterol (LDL-C) through PCSK9 inhibition represents a new therapeutic approach to preventing and treating cardiovascular disease (CVD). Phenome-wide analyses of PCSK9 genetic variants in large prospective biobanks can help to identify unexpected effects of PCSK9 inhibition. <h4>Methods</h4> The prospective China Kadoorie Biobank genotyped >100,000 participan...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8a4257ce-2d64-5f93-9c12-f8c63d2cc37b
- DOI
- 10.1101/2023.08.15.23294117
